We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 376

Patent found not to be infringed following construction of the term "independently"
  • Borden Ladner Gervais LLP
  • Canada
  • October 19 2016

Cascade is the owner of a Canadian patent related to a safety locking device for quick couplers and claims that Kinshofer have infringed or induced


Court Grants Order Correcting Inventorship, but Declines to Order Recording of Documents at Patent Office
  • Borden Ladner Gervais LLP
  • Canada
  • October 12 2016

Qualcomm sought an order pursuant to s. 52 of the Patent Act to add Mr. Rychlik as the sole inventor and to remove two of the named inventors. The


Expert "Blinding" is a Question of Relevance, Reliability and Weight, but not Admissibility
  • Borden Ladner Gervais LLP
  • Canada
  • October 12 2016

On August 23, 2016, the Federal Court released its public judgment granting the Order of prohibition for Gilead's ‘619 Patent. The ‘619 Patent


Court holds claims not infringed, and if a claim was infringed on the basis of a different construction, the claim would be invalid by reason of obviousness
  • Borden Ladner Gervais LLP
  • Canada
  • October 5 2016

This action for infringement concerned Arctic Cat's (AC) '738 Patent, which addressed two-stroke engines where the exhaust gas temperature is used for


NOA found to be deficient for failing to plead the facts and law relating to the manufacture and importation of the drug product
  • Borden Ladner Gervais LLP
  • Canada
  • October 5 2016

Bayer has obtained an order of prohibition against the Minister of Health from issuing a NOC to Fresenius for its proposed moxifloxacin hydrochloride


Intellectual Property Weekly Abstracts Bulletin
  • Borden Ladner Gervais LLP
  • Canada
  • September 28 2016

In a patent infringement action, the defendant brought a motion relating to read-ins of portions of the Examinations for discovery. In particular, the


Court of Appeal upholds construction of the promise distinguishing between the compounds and use claims
  • Borden Ladner Gervais LLP
  • Canada
  • September 21 2016

The Federal Court of Appeal dismissed an appeal from a decision prohibiting the Minister of Health from issuing a Notice of Compliance to Teva for


Trial judge acknowledges stare decisis and comity in relation to findings from the previous NOC proceedings
  • Borden Ladner Gervais LLP
  • Canada
  • September 21 2016

This was a patent infringement action against Apotex and Cobalt, relating to a combination of drospirenone and ethinylestradiol for an effective oral


Two panel Court of Appeal does not have subject-matter jurisdiction in this case to vary its three panel judgment
  • Borden Ladner Gervais LLP
  • Canada
  • September 21 2016

Pfizer moved for an order reconsidering and varying the judgment of the Court of Appeal's decision in 2016 FCA 161, summarized the week of June 13


Court of appeal upholds finding of infringement and only requires a "mere scintilla" of utility
  • Borden Ladner Gervais LLP
  • Canada
  • September 21 2016

The Federal Court of Appeal has dismissed Nova's appeal of an earlier finding that it had infringed Dow's patent relating to polyethylene used to make